California's mountains have risen more than half an inch, thanks to the absence of water to weigh them down, a study found. NBC News reports.» Read More
DSM Chairman and CEO Feike Sijbesma told CNBC he expects the Dutch chemicals firm to perform well in the second half of the year following strong second quarter results which saw a boost in net profit, while revenue fell just shy of the Reuters average forecast.
What are some of the more notable products available on the market today that are said to enhance athletic performance? Click ahead and find out.
CNBC.com collected the annual salaries of employees in 10 high-earning government jobs, and compared them with salaries from the same jobs in the private sector. Check out the list!
Age is just a number. Unfortunately, this axiom doesn’t always apply when it comes to professional sports. Who are the 10 most notable athletes still active after the age of 40?
Swiss drugs industry supplier Lonza is to buy U.S.-listed Arch Chemicals for some $1.2 billion, creating the world's largest player in the microbial control market, the groups said on Monday.
Our special report, "NASA: The Next Generation," explores the impact of the space shuttle's end to the future of the agency and America's place in space.
Supporters say it is premature without a replacement to the space craft, while opponents say the returns don't justify the cost.
How much do you know about NASA's space program? Take our quiz.
From Florida's Space Coast to contractors in Connecticut and Georgia. jobs and business will be lost — some, probably forever.
The end of NASA’s space shuttle program will limit U.S. manned flight in the short term but is unlikely to threaten the country's long-term competitiveness in the space sector.
The space agency is leaving the low-orbit travel to the private sector and focusing its R&D efforts on exploring deep space.
With the final space shuttle flying, many wonder, what’s next? Well, tighten your seat belt. The second great space race is about to begin and it could shave two to three years off astronauts' down time without something American to fly.
The fear in the area surrounding Kennedy Space Center is that when the Shuttle program ends this month, it will become the "Ghost Coast".
Eli Lilly signaled it could maintain or even boost research spending through 2014, even as company sales and earnings tumble due to expected generic competition for its biggest-selling medicines.
The problems facing US healthcare have not yet been fully resolved, according to the chief executive of AstraZeneca.
A new machine used in Germany decodes the E.Coli strain. Insight on whether this technology can be a breakthrough in the stock, with Jonathan Rothberg, Ion Torrent CEO.
The Centers for Disease Control considers obesity in America an epidemic; more than one out of three adults and 17 percent of all children are technically overweight to the point of obesity.
The government is making an increasing number of expensive life-saving or life extending drugs and devices available to more people, but is that the right thing to do and can we afford it, anyway?
Health care is an emotional subject for many Americans — and often one of extremes. Yet, as we obssess about the system's structure and cost, we neglect our own health. Obesity and high blood pressure are more common, while exercise and diet are overlooked. Our special report, "Healthy Business", explores these issues.
More and more American women are seeking infertility treatment to increase their chances of having a child, but there's been no change in success rates and costs remain high, even with health insurance coverage.